TENET HEALTHCARE CORP 8K

Tenet Healthcare reported strong Q2 2026 results, raised its 2026 earnings and cash flow outlook, and expanded its share repurchase authorization by $2.0 billion.

Tenet Healthcare Corporation reported significantly improved second quarter 2026 financial results, highlighted by a sharp increase in net income to $826 million ($9.84 per diluted share) from $288 million ($3.14 per diluted share) a year earlier, a 16.3% rise in consolidated Adjusted EBITDA to $1.304 billion with stronger margins in both ambulatory and hospital segments, and robust operating cash flows, and concurrently raised its full-year 2026 outlook for Adjusted EBITDA to $4.83–$5.03 billion and Adjusted Free Cash Flow to $2.725–$3.025 billion while authorizing a $2.0 billion increase to its share repurchase program, leaving $2.13 billion remaining for buybacks as of July 23, 2026.

Filing Facts

CIK

70318

Ticker

THC

Form

8K

Source Type

sec

Accession

0000070318-26-000032

Alert Tier

7